Benchmark analyst Matthew Harrigan even boosted his stock price target by $7 to $25 following Tuesday's news that the conglomerate's board will review various deal and other options. By Georg Szalai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback